Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Stool DNA testing for cancer surveillance in inflammatory bowel disease: an early view.

Kisiel JB, Ahlquist DA.

Therap Adv Gastroenterol. 2013 Sep;6(5):371-80. doi: 10.1177/1756283X13487941.

2.

Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.

Health Quality Ontario..

Ont Health Technol Assess Ser. 2009;9(10):1-40.

3.

Stool DNA testing for the detection of colorectal neoplasia in patients with inflammatory bowel disease.

Kisiel JB, Yab TC, Nazer Hussain FT, Taylor WR, Garrity-Park MM, Sandborn WJ, Loftus EV, Wolff BG, Smyrk TC, Itzkowitz SH, Rubin DT, Zou H, Mahoney DW, Ahlquist DA.

Aliment Pharmacol Ther. 2013 Mar;37(5):546-54. doi: 10.1111/apt.12218.

4.

Screening for Colorectal Cancer: A Systematic Review for the U.S. Preventive Services Task Force [Internet].

Lin JS, Piper MA, Perdue LA, Rutter C, Webber EM, O’Connor E, Smith N, Whitlock EP.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Jun.

5.

Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?

Dyson JK, Rutter MD.

World J Gastroenterol. 2012 Aug 7;18(29):3839-48. doi: 10.3748/wjg.v18.i29.3839. Review.

6.

Colorectal Cancer in Patients With Inflammatory Bowel Disease: The Need for a Real Surveillance Program.

Fornaro R, Caratto M, Caratto E, Caristo G, Fornaro F, Giovinazzo D, Sticchi C, Casaccia M, Andorno E.

Clin Colorectal Cancer. 2016 Sep;15(3):204-12. doi: 10.1016/j.clcc.2016.02.002. Review.

PMID:
27083409
7.

Current management of inflammatory bowel disease and colorectal cancer.

Mattar MC, Lough D, Pishvaian MJ, Charabaty A.

Gastrointest Cancer Res. 2011 Mar;4(2):53-61.

8.

Colon cancer in inflammatory bowel disease: recent trends, questions and answers.

Viennot S, Deleporte A, Moussata D, Nancey S, Flourié B, Reimund JM.

Gastroenterol Clin Biol. 2009 Jun;33 Suppl 3:S190-201. doi: 10.1016/S0399-8320(09)73154-9.

9.

Colon cancer screening and surveillance in inflammatory bowel disease.

Bae SI, Kim YS.

Clin Endosc. 2014 Nov;47(6):509-15. doi: 10.5946/ce.2014.47.6.509. Review.

10.

Cost-Effectiveness of DNA Stool Testing to Screen for Colorectal Cancer [Internet].

Zauber AG, Lansdorp-Vogelaar I, Wilschut J, Knudsen AB, van Ballegooijen M, Kuntz KM.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2007 Dec 20.

11.

Colorectal cancer surveillance in inflammatory bowel disease: A critical analysis.

Desai D, Desai N.

World J Gastrointest Endosc. 2014 Nov 16;6(11):541-8. doi: 10.4253/wjge.v6.i11.541. Review.

12.

DNA Methylation and Mutation of Small Colonic Neoplasms in Ulcerative Colitis and Crohn's Colitis: Implications for Surveillance.

Johnson DH, Taylor WR, Aboelsoud MM, Foote PH, Yab TC, Cao X, Smyrk TC, Loftus EV Jr, Mahoney DW, Ahlquist DA, Kisiel JB.

Inflamm Bowel Dis. 2016 Jul;22(7):1559-67. doi: 10.1097/MIB.0000000000000795.

PMID:
27104828
13.

Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey.

Baars JE, Kuipers EJ, van Haastert M, Nicolaï JJ, Poen AC, van der Woude CJ.

J Gastroenterol. 2012 Dec;47(12):1308-22. doi: 10.1007/s00535-012-0603-2.

14.

Rate of early/missed colorectal cancers after colonoscopy in older patients with or without inflammatory bowel disease in the United States.

Wang YR, Cangemi JR, Loftus EV Jr, Picco MF.

Am J Gastroenterol. 2013 Mar;108(3):444-9. doi: 10.1038/ajg.2012.429.

PMID:
23295277
15.

Stool screening for colorectal cancer: molecular approaches.

Osborn NK, Ahlquist DA.

Gastroenterology. 2005 Jan;128(1):192-206. Review.

PMID:
15633136
16.

Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis.

Kim ER, Chang DK.

World J Gastroenterol. 2014 Aug 7;20(29):9872-81. doi: 10.3748/wjg.v20.i29.9872. Review.

17.

Colorectal Cancer in Inflammatory Bowel Disease: Epidemiology, Pathogenesis and Surveillance.

Wang ZH, Fang JY.

Gastrointest Tumors. 2014 Aug;1(3):146-54. doi: 10.1159/000365309. Review.

18.

Colorectal cancer surveillance in inflammatory bowel disease: the search continues.

Ahmadi A, Polyak S, Draganov PV.

World J Gastroenterol. 2009 Jan 7;15(1):61-6. Review.

19.

Colorectal cancer in patients with inflammatory bowel disease: the true impact of the risk.

Herszényi L, Barabás L, Miheller P, Tulassay Z.

Dig Dis. 2015;33(1):52-7. doi: 10.1159/000368447. Review.

PMID:
25531497
20.

Molecular Alterations of Colorectal Cancer with Inflammatory Bowel Disease.

Yashiro M.

Dig Dis Sci. 2015 Aug;60(8):2251-63. doi: 10.1007/s10620-015-3646-4. Review.

PMID:
25840920
Items per page

Supplemental Content

Support Center